Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_assertion type Assertion NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_head.
- NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_provenance.
- NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_assertion evidence source_evidence_literature NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_provenance.
- NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_assertion SIO_000772 21942912 NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_provenance.
- NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_assertion wasDerivedFrom befree-2016 NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_provenance.
- NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_assertion wasGeneratedBy ECO_0000203 NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_provenance.